Skip to main content
. 2024 Aug 19;3(10):101214. doi: 10.1016/j.jacadv.2024.101214

Figure 4.

Figure 4

Cardiac Sarcoidosis

(A) A 12-lead electrocardiogram showing an intraventricular conduction disturbance and polymorphic ventricular ectopic beats. (B) The 18-FDG myocardial PET demonstrating patchy/diffuse hypermetabolic activity. (C) Two-dimensional echocardiography speckle tracking analysis highlighting the impairment of the lateral wall. (D) Short-axis CMR image showing multifocal patchy enhancement in the inferoseptum and anterolateral and inferior LV walls. Notice how the enhancement correlates to segments with high metabolic activity. CMR = cardiac magnetic resonance; FDG = fluorodeoxyglucose; PET = positron emission tomography.